Why the study?
Does autonomic reinnervation improve exercise performance and survival in pediatric heart transplant recipients?
Does autonomic reinnervation improve exercise performance and survival in pediatric heart transplant recipients?
Autonomic reinnervation occurs in a majority of pediatric heart transplant recipients and is associated with improved exercise capacity and a lower risk of mortality or retransplantation.
Answers are grounded in this paper and cite their sources.
Reinnervation may confer exercise and survival benefits in pediatric heart transplant recipients; hypothesis-generating pending prospective confirmation.
Following heart transplantation (HTx), loss of autonomic input to the allograft results in elevated resting heart rate (HR) and decreased chronotropic reserve. As enhanced exercise capacity and HR recovery post exercise are suggestive of reinnervation in pediatric cohorts, we used heart rate variability (HRV) analysis to assess autonomic reinnervation in pediatric HTx recipients. Pediatric patients transplanted between 1996 and 2010 and with serial 24-hour Holter recordings post-HTx were analyzed for HRV using time and frequency domain measures. Of 112 patients, 68 (57%) showed evidence of autonomic reinnervation that was not associated with age at HTx. Evidence of reinnervation was associated with a significant increase in low-frequency power spectrum (p<0.001), suggesting sympathetic reinnervation. Patients with evidence of reinnervation showed higher percent-predicted maxVO(2) on performing an exercise test (+10.2 ± 3.6%, p = 0.006) and improved HR recovery at 3 minutes (-11.4 ± 3.9 bpm, p = 0.004), but no difference in percent-predicted maximal HR. Cox hazards modeling using presumed sinus reinnervation criteria at last Holter recording as a time-dependent covariate was associated with decreased hazard of mortality and/or retransplantation (HR: 0.2, 95% CI 0.04-1.0, p = 0.05). In conclusion, a majority of pediatric HTx recipients demonstrate evidence of reinnervation that is associated with functional outcomes. Studies to assess graft reinnervation as a marker of long-term prognosis are warranted.
No takes yet. Share an insight, caveat, or question.
Vanderlaan et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: